Patents by Inventor Wendi Veloso Rodrigueza

Wendi Veloso Rodrigueza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNAI FOR THE MODULATION OF GENES
    Publication number: 20160040163
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition genes implicated in many diseases.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 11, 2016
    Inventors: Wendi Veloso RODRIGUEZA, Mina Patel SOOCH, Michael WOOLLISCROFT, Rachel WEINGRAD, Richard Adam MESSMANN, Abhishek MANJUNATHAN
  • Methods of Using Biomarkers for the Treatment of Cancer by Modulation of BCL2 Expression
    Publication number: 20150299803
    Abstract: The present invention relates to cancer therapies and methods of using the same. In particular, the present invention provides methods of monitoring and improving the administration of cancer therapies, wherein the cancer is mediated by the BCL2 oncogene, via markers of disease identification, disease progression, drug resistance, and/or treatment efficacy.
    Type: Application
    Filed: November 5, 2013
    Publication date: October 22, 2015
    Inventors: Wendi Veloso Rodrigueza, Robert T. Streeper, Elzbieta Izbicka, Mina Patel Sooch, Michael James Woolliscroft, Richard Adam Messmann, Shari Kay Gaylor
  • Dosing and Administration of Oligonucleotide Cancer Therapies
    Publication number: 20150272980
    Abstract: The present invention relates to cancer therapies, compositions, and methods of using the same. In particular, the present invention provides methods of dosing and administration of cancer therapies comprising the administration of oligomers and liposome formulations of oligomers, wherein the cancer is mediated by the bcl-2 oncogene. In some aspects, the oligomers or liposome formulations of oligomers are administered in combination with one or more other therapeutic agents.
    Type: Application
    Filed: November 5, 2013
    Publication date: October 1, 2015
    Inventors: Wendi Veloso Rodrigueza, Mina Patel Sooch, Shari Kay Gaylor, Richard Adam Messman, Michael James Woolliscroft